US Patent Issued to Opus Genetics on March 17 for "Methods and compositions for treatment of mydriasis" (Michigan, Washington, Illinois Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,066, issued on March 17, was assigned to Opus Genetics Inc. (Durham, N.C.).

"Methods and compositions for treatment of mydriasis" was invented by Mina Sooch (Bloomfield, Mich.), Alan R. Meyer (North Riverside, Ill.), Konstantinos Charizanis (Ypsilanti, Mich.), Bernhard Hoffmann (Lake Forest, Ill.) and William H. Pitlick (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods, compositions, and kits containing an alpha-adrenergic antagonist, such as phentolamine, for use in monotherapy or as part of a combination therapy to treat patients suffering from presbyopia, mydriasis, and/or other ocular disorders."

The patent...